-+ 0.00%
-+ 0.00%
-+ 0.00%

INCYTE ANNOUNCES EUROPEAN COMMISSION APPROVAL OF MINJUVI® (TAFASITAMAB) FOR THE TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Reuters·12/17/2025 16:20:00

Please log in to view news